The Food and Drug Administration on Monday approved the first new treatment for Alzheimer’s disease in nearly two decades, a landmark decision that has been eagerly awaited by millions of Americans diagnosed with the condition but that will be hotly contested by some in the scientific community who doubt the drug’s effectiveness. Read More…
Read More Health Tips :
NPR: Alzheimer's drug gets full FDA approval. Medicare coverage will likely follow NPR: CDC recommends 2nd COVID boosters for some older and immunocompromised people FDA Grants Historic Approval to Alzheimer’s drug Designed to Slow Cognitive Decline Texas Assisted Living Facilities Receive COVID-19 Vaccine
